US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Abstract, Snapshot, Market Analysis & Market Definition: Global Artificial Insemination Market The global artificial insemination market size was valued at USD 1.5 billion in 2018 and is projected to expand at a CAGR of 8.4% over the forecast period. According to the WHO, around 10% of women are directly or indirectly affected by infertility. In addition, National Institutes of Health reported that infertility affects around 12% of couples of reproductive age. The WHO monitors infertility prevalence across the globe in line with ‘WHO Reproductive Health Indicators, Guidelines for their generation, interpretation, and analysis for global monitoring’. According to the United Nations, the global fertility rate is expected to decline to 2.4% by 2030 and 2.2% by 2050. In some countries, including U.S. and U.K., same-sex couples are provided insurance coverage for artificial insemination procedures. As per the National Institute for Health and Clinical Excellence (NICE) guidelines, same-sex couples should be eligible to avail fertility treatments. The NHS expects such couples to have undergone six cycles of self-funded artificial insemination to be able to avail NHS-funded fertility treatments. Artificial insemination is a first-line of infertility treatment, as it is minimally invasive and less expensive as compared to IVF. Intrauterine insemination held majority of the market share in 2018 and is likely to be the fastest-growing segment over the forecast period as it is the most common and non-invasive procedure. Fertility clinics held a majority of the market share in the year 2018 due to higher number of medical facilities offering infertility treatments. Europe held a majority of the market share in the year 2018. North America was the second-largest market in 2018. Some of the key companies in the global artificial insemination market include Vitrolife; Genea Ltd.; Rinovum Women’s Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; Kitazato Corp.; and Rocket Medical plc. Market Segmentation, Outlook & Viewpoint: Global Artificial Insemination Market Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026) Intrauterine Intracervical Intravaginal Intratubal End Use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026) Fertility Clinics & Other Facilities Home Source Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026) AIH-Husband AID-Donor Key Players, Recent Developments & Regional Insights: Global Artificial Insemination Market Fertility clinics held the largest market share in 2018 and are likely to be the fastest-growing end-use segment over the forecast period. The number of medical centers offering infertility treatment has increased over the past few years due to rising infertility rates across the world. All the types of artificial insemination procedures can be performed at fertility clinics. Mostly, Intrauterine (IUI) and Intratubal (ITI) procedures are performed in fertility clinics. Insemination procedures at clinics involve consultation, which includes determination of ovulation cycle before initiating the procedures. In addition, doctors can prescribe fertility medications to increase the chances of conception. Source Type Insights Artificial Insemination by Husband (AIH) segment led the market. It is also expected to witness the fastest CAGR over the forecast period. Donor insemination (AID) is opted as a last alternative by couples with non-viable sperm. Single women or same-sex couples can also choose AID. Donor insemination has proven to be safe as sperm banks are supposed to provide personal medical and extensive family histories of donors. Regional Insights Europe was the largest regional market in 2018 as the fertility rate in the region has been decreasing over the years. Delay in pregnancy and lifestyle changes are among the factors contributing to this decline. North America was the second-largest market. There were only 62.5 births per 1000 women, according to the National Center for Health Statistics. Asia Pacific is expected to be the fastest-growing market in the forecast years due to increasing infertility rate and rising awareness about the available treatment options. Artificial Insemination Market Share Insights Some of the key companies in the market are Vitrolife; Genea Limited; Rinovum Women’s Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; KITAZATO CORPORATION; Rocket Medical plc. Companies focus on acquisition of small firms to strengthen their presence in regional markets. For instance, in March 2018, JXTGE announced the sale of Irvine Scientific to FUJIFILM, which acquired the company to maximize its synergy and maintain its growth in the biomedical industry. The acquisition was completed in June 2018. Key Insights Covered: Global Artificial Insemination Market 1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Artificial Insemination industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Artificial Insemination industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Artificial Insemination industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Artificial Insemination industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Artificial Insemination industry. Research Methodology: Global Artificial Insemination Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Table of Contents Chapter 1 Methodology And Scope 1.1 Market Segmentation & Scope 1.1.1 Type 1.1.2 End Use 1.1.3 Source Type 1.1.4 Regional Scope 1.1.5 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information procurement 1.3.1 Purchased Database 1.3.2. HCC’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.2 Volume Price An | read more...